David Mcgirr, Director at Rhythm Pharmaceuticals, holds 11.71K shares in Rhythm Pharmaceuticals (Ticker: RYTM), holds ― shares in Yarrow Bioscience (Ticker: YARW), holds 97.72K shares in Insmed (Ticker: INSM).
David Mcgirr latest transaction was an Uninformative Buy of $500.37K.
What was David Mcgirr's most profitable transaction?
David Mcgirr’s most profitable transaction was an Informative Buy of ROKA stock on November 17, 2014. The return on the trade was -66.60%.
What is David Mcgirr's role in Rhythm Pharmaceuticals?
David Mcgirr's role in Rhythm Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.